|
Dr. Ingenito is Angiotech's Chief Clinical and Regulatory Affairs Officer and provides the company with strategic insight, leadership and direction for its worldwide clinical development and regulatory activities. Dr. Ingenito brings a wealth of clinical and regulatory experience and knowledge to Angiotech having held previous executive positions in large and medium-sized pharmaceutical companies as well as clinical research organizations.
He joins Angiotech from SFBC International, a major contract research organization acting as Senior Vice President. Prior to joining SFBC, Dr. Ingenito was Chief Operating Officer at Otsuka Maryland Research Institute of Otsuka Pharmaceuticals where he had extensive involvement with the US Food and Drug Administration.
Dr. Ingenito received a PhD from Thomas Jefferson University, an MD from Jefferson Medical College and a BA from Johns Hopkins University. He completed his post-graduate residency at the University of Miami. | 